Niloofar Rahmani

Array ( [id] => 5673017 [patent_doc_number] => 20060178372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Therapeutic quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/397081 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33532 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178372.pdf [firstpage_image] =>[orig_patent_app_number] => 11397081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123078 [patent_doc_number] => 07704991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 11/887622 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7034 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704991.pdf [firstpage_image] =>[orig_patent_app_number] => 11887622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502845 [patent_doc_number] => 20090163533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => '1-Substituted Pyrazolo (3,4-C) Ring Compounds as Modulators of Cytokine Biosynthesis for the Treatment of Viral Infections and Neoplastic Diseases' [patent_app_type] => utility [patent_app_number] => 11/887492 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37766 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163533.pdf [firstpage_image] =>[orig_patent_app_number] => 11887492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4470096 [patent_doc_number] => 07943610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Pyrazolopyridine-1,4-diamines and analogs thereof' [patent_app_type] => utility [patent_app_number] => 11/887524 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27570 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943610.pdf [firstpage_image] =>[orig_patent_app_number] => 11887524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142342 [patent_doc_number] => 07687646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof' [patent_app_type] => utility [patent_app_number] => 11/392098 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16241 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687646.pdf [firstpage_image] =>[orig_patent_app_number] => 11392098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700732 [patent_doc_number] => 20060217417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF PKC-THETA' [patent_app_type] => utility [patent_app_number] => 11/277536 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10047 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217417.pdf [firstpage_image] =>[orig_patent_app_number] => 11277536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754733 [patent_doc_number] => 20060223882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Amorphous simvastatin' [patent_app_type] => utility [patent_app_number] => 11/386962 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2405 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223882.pdf [firstpage_image] =>[orig_patent_app_number] => 11386962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664451 [patent_doc_number] => 20080255358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases' [patent_app_type] => utility [patent_app_number] => 11/909114 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36933 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255358.pdf [firstpage_image] =>[orig_patent_app_number] => 11909114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851694 [patent_doc_number] => 20060234885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Cyclopropanated macrocyclic ketones and lactones' [patent_app_type] => utility [patent_app_number] => 11/386957 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4491 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234885.pdf [firstpage_image] =>[orig_patent_app_number] => 11386957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673054 [patent_doc_number] => 20060178409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/374720 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7519 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178409.pdf [firstpage_image] =>[orig_patent_app_number] => 11374720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632355 [patent_doc_number] => 20060148825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => '1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives' [patent_app_type] => utility [patent_app_number] => 11/370451 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6417 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148825.pdf [firstpage_image] =>[orig_patent_app_number] => 11370451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386705 [patent_doc_number] => 07304074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Substituted 1,5-naphthyridine azolinones' [patent_app_type] => utility [patent_app_number] => 11/368936 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14560 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304074.pdf [firstpage_image] =>[orig_patent_app_number] => 11368936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619254 [patent_doc_number] => 07998974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Fused heterocyclic compounds and their use as sirtuin modulators' [patent_app_type] => utility [patent_app_number] => 11/885576 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54395 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998974.pdf [firstpage_image] =>[orig_patent_app_number] => 11885576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786604 [patent_doc_number] => 20060205718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives' [patent_app_type] => utility [patent_app_number] => 11/366516 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60221 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205718.pdf [firstpage_image] =>[orig_patent_app_number] => 11366516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8017349 [patent_doc_number] => 08138177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Benzimidazolone derivatives as CB2 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/909763 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47512 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138177.pdf [firstpage_image] =>[orig_patent_app_number] => 11909763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4548833 [patent_doc_number] => 07960407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Crystal forms of an imidazole derivative' [patent_app_type] => utility [patent_app_number] => 11/908163 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17969 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960407.pdf [firstpage_image] =>[orig_patent_app_number] => 11908163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584581 [patent_doc_number] => 07446114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Quinolinone compounds as 5-HT4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/365320 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38312 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446114.pdf [firstpage_image] =>[orig_patent_app_number] => 11365320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620273 [patent_doc_number] => 20060189807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Process for the manufacture of intermediates in camptothecin production' [patent_app_type] => utility [patent_app_number] => 11/357273 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10638 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189807.pdf [firstpage_image] =>[orig_patent_app_number] => 11357273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856969 [patent_doc_number] => 07375229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/276203 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13396 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375229.pdf [firstpage_image] =>[orig_patent_app_number] => 11276203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297188 [patent_doc_number] => 20090012114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same' [patent_app_type] => utility [patent_app_number] => 11/816420 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16266 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012114.pdf [firstpage_image] =>[orig_patent_app_number] => 11816420 [rel_patent_id] =>[rel_patent_doc_number] =>)